已收盤 03-27 16:00:00 美东时间
-0.220
-5.66%
绩优股成避风港!AI软件股Navan暴涨43%、Precigen涨超25%;中东局势再生变数!无人机公司Swarmer隔夜大涨15%>>
03-27 19:20
今日重点评级关注:HC Wainwright & Co.:维持Atossa Therapeutics"买入"评级,目标价从7美元升至25美元;Needham:维持Nkarta"买入"评级,目标价从10美元升至11美元
03-27 10:22
Olaplex Holdings shares surge 51% after being acquired by Henkel AG & Co. KGaA. Other big gainers include Kodiak Sciences Inc and Precigen Inc.
03-26 22:04
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Precigen (NASDAQ:PGEN) with a Buy and raises the price target from $9 to $10.
03-26 20:41
Precigen shares are trading higher after the company reported better-than-expec...
03-26 20:18
Shares of Navan Inc (NASDAQ: NAVN) spiked in pre-market trading on better-than-expected Q4 results. Gainers include EEIQ, FCHL, OLPX, SLND, PGEN, EDHL, NFGC, NEXT, and VG. Losers include MGN, CBUS, HUBC, and UGRO.
03-26 17:47
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据Precigen业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **营收表现:** - 2025财年总收入970万美元,较2024财年320万美元增长149% - 净产品收入340万美元,主要来自2025年11月开始的Papzimius商业化销售 - Q4净产品收入340万美元(仅反映11月开始的部分季度销售) **盈利状况:** - 归属于普通股股东的净亏损4.296亿美元,每股亏损1.37美元 - 净亏损中包含3.185亿美元(每股1.02美元)的优先股认股权证相关非现金费用 **现金状况:** - 年末现金、现金等价物及投资总额
03-26 12:09
Precigen (NASDAQ:PGEN) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.08) by 87.95 percent. This is a 83.33 percent increase over losses of $(0.06) per share from the same
03-26 04:10
Companies Reporting Before The Bell • Chewy (NYSE:CHWY) is expected to report q...
03-25 19:11
Gainers Icecure Medical (NASDAQ:ICCM) shares moved upwards by 17.7% to $0.68 d...
03-02 20:05